hasINN

P23160
predicate

Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.

All labels observed (1)

Label Occurrences
hasINN canonical 30

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasINN
Generated description
Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.

Sample triples (30)

Subject Object
Leqembi lecanemab ⓘ
linked to: Leqembi
Imbruvica ibrutinib ⓘ
Avastin bevacizumab ⓘ
linked to: Avastin
Rituxan rituximab ⓘ
linked to: Rituxan
Donepezil donepezil ⓘ
linked to: Donepezil
Alimta pemetrexed ⓘ
linked to: Alimta
Emgality galcanezumab ⓘ
linked to: Emgality
Ruxience rituximab ⓘ
linked to: Rituxan
Keytruda pembrolizumab ⓘ
linked to: Keytruda
maftivimab maftivimab ⓘ
Inmazeb atoltivimab ⓘ
Inmazeb maftivimab ⓘ
Inmazeb odesivimab ⓘ
Ibrance palbociclib ⓘ
linked to: Ibrance
Imfinzi durvalumab ⓘ
fingolimod fingolimod ⓘ
larotrectinib larotrectinib ⓘ
selpercatinib selpercatinib ⓘ
inotersen inotersen ⓘ
Humira adalimumab ⓘ
Hemlibra emicizumab ⓘ
Vabysmo faricimab ⓘ
rosuvastatin rosuvastatin ⓘ
sulfasalazine sulfasalazine ⓘ
Andexxa andexanet alfa ⓘ
Ondexxya andexanet alfa ⓘ
isatuximab isatuximab ⓘ
Zabdeno Ad26.ZEBOV ⓘ
acalabrutinib acalabrutinib ⓘ
neratinib neratinib ⓘ